Donate
Panelists on stage at the Global HPV Consortium

The Global HPV Consortium

A public-private movement to prevent Human Papilloma Virus (HPV) infection and eliminate cervical cancer as a public health concern.

September 5 - 6, 2023 | Kuala Lumpur, Malaysia

Global HPV Consortium Takes Flight

Sabin and partners united in Kuala Lumpur, Malaysia for the official launch of the Global HPV Consortium on September 5. A select few resources from the event below.

  • 600,000
    New cases of cervical cancer annually
  • 340,000
    Cervical cancer deaths each year
  • 1 in 7
    Eligible girls currently vaccinated

An increased sense of urgency is needed as the world falls behind

Since introduction in 2006, HPV vaccines have proven safe and effective in protecting against infection and preventing cervical cancer. Yet, the burden of HPV diseases continues to rise with an estimated 600,000 new cases of cervical cancer and over 340,000 deaths each year.

To respond to these life-threatening trends, the Sabin Vaccine Institute, as consortium secretariat, along with a diverse, and expanding, set of partners will mobilize action across three pillars:

The Global HPV Consortium will be guided by global goals, including WHO’s Immunization Agenda 2030 and Cervical Cancer Elimination Initiative:

Who We Are

We're a trans-disciplinary alliance committed to sustained engagement
  • Independent and unique consortium of diverse multi-sectoral partners
  • Driving engagement that can last across all levels of governance and implementation
Untapped-Potential
We work at multiple levels: global, regional, country, sub-national, and local
  • Surfacing the needs, opportunities, and challenges from stakeholders across levels, particularly those who work within local communities so that those closest to the problems are part of the solutions
  • Amplifying the voices of women, youth, and community-based organizations at the grassroots level
Healthcare-Worker
We center efforts on low- and middle- income countries and among vulnerable populations
  • Promoting the value of integrating vaccination (prevention), screening and treatment of pre-cancerous lesions in communities, especially those at high risk for HPV and cervical cancer
  • Facilitating fresh thinking around tried approaches and harnessing research, new technology, and data to catalyze positive change
Communities

Consortium Partners

The Consortium partners will have an opportunity to contribute in a variety of ways:

Financial Partners

Providing financial resources to sustain the Consortium and support activities within the Action Plan.

Technical & Knowledge Partners

Contributing technical expertise and skills to the development of Consortium knowledge, training, and mentoring assets and activities.

Advocacy Partners

Giving voice to the goals of the Consortium and working in partnership to extend the impact of its work through their networks.

The Action Plan will include impactful and actionable steps to deliver on the promise of protection against the devastating effects of HPV through primary and secondary prevention.

The Plan will:
  • Be informed by a sustained and dynamic community of global, national and sub-national stakeholders.
  • Encompass issues from political commitment, financing, policy, through to community-level service delivery.
  • Promote an on-the-ground alliance and convergence of multi-sectoral actors and institutions.
  • Spotlight the voices of women, young people, and those most vulnerable to HPV and cervical cancer.
  • Listen to and learn from communities about their needs and aspirations and activate impactful response.
  • Spur and scale-up local innovation.

The Plan’s actionable framework will deliver on the promise of protection from HPV and cervical cancer by:

  • Establishing feedback loops from global to sub-national levels for connection and accountability
  • Dynamically distilling & disseminating best practices
  • Applying a social & behavioral lens to HPV vaccine acceptance and demand challenges & solutions
  • Fostering adaptive service delivery and leadership throughout the value chain
  • Driving investment in innovation & impact
  • Generating new knowledge and evidence

Latest HPV Resources